What is the most likely finding on funduscopic exam in a patient with subarachnoid hemorrhage (SAH) and hydrocephalus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Funduscopic Findings in Subarachnoid Hemorrhage with Hydrocephalus

The most likely funduscopic finding in this patient with subarachnoid hemorrhage (SAH) and acute hydrocephalus is intraocular hemorrhage, specifically subhyaloid or vitreous hemorrhage (Terson syndrome).

Clinical Context

This 28-year-old patient presents with classic SAH features—sudden severe headache, neck stiffness, vomiting, and depressed consciousness—with CT confirmation showing blood in cisternal spaces, third ventricle, and lateral ventricles with associated hydrocephalus 1. The presence of intraventricular hemorrhage and hydrocephalus are significant findings that correlate with specific ocular manifestations 2.

Funduscopic Findings in SAH

Intraocular Hemorrhage (Terson Syndrome)

  • Intraocular hemorrhage occurs in approximately 10-40% of patients with aneurysmal SAH, manifesting as subhyaloid, intraretinal, or vitreous hemorrhage 1
  • The mechanism involves sudden elevation of intracranial pressure at the moment of aneurysm rupture, which transmits through the optic nerve sheath, causing rupture of retinal vessels 3
  • This finding is particularly associated with severe SAH grades and the presence of intraventricular hemorrhage, both of which are present in this patient 2

Why Not the Other Options?

Cotton wool spots are characteristic of hypertensive retinopathy, diabetic retinopathy, or vasculitis—not acute SAH 4. While this patient has risk factors (smoking, amphetamine use) for hypertension, cotton wool spots represent chronic microvascular ischemia rather than acute hemorrhagic events.

Increased optic cup-to-disc ratio indicates chronic glaucomatous damage developing over months to years, which is irrelevant to acute SAH presentation 4.

Pale optic disc suggests chronic optic atrophy from longstanding compression or ischemia, not an acute finding in SAH 4.

Papilledema Consideration

While acute hydrocephalus can theoretically cause elevated intracranial pressure and papilledema, papilledema typically requires sustained elevated ICP over days to weeks to develop visible disc swelling 4. In the acute setting described (patient just arriving to the emergency department), papilledema would not yet be apparent even if ICP is elevated 1.

Acute hydrocephalus occurs in 20-30% of SAH patients within 72 hours, and while it can cause elevated ICP requiring ventricular drainage, the funduscopic changes of papilledema lag behind the acute pressure elevation 1, 2.

Clinical Implications

  • The presence of intraocular hemorrhage in SAH correlates with poor clinical grade and worse outcomes 1, 3
  • This patient's acute hydrocephalus (evidenced by ventricular enlargement on CT) requires urgent external ventricular drainage, which can be performed safely without increasing rebleeding risk 2
  • Approximately 40-80% of patients with diminished consciousness from acute hydrocephalus show improvement after CSF diversion 1

Management Priority

Immediate neurosurgical consultation for external ventricular drain placement is indicated given the depressed consciousness and radiographic hydrocephalus 1, 2. The funduscopic finding of intraocular hemorrhage, while diagnostically significant, does not alter acute management priorities focused on securing the aneurysm and managing elevated ICP 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute hydrocephalus following aneurysmal subarachnoid hemorrhage.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1996

Related Questions

For a patient with subarachnoid hemorrhage who is restless, agitated, and has a severe headache, which of the following changes—decreased systolic blood pressure (mean arterial pressure still within target), slight increase in restlessness without change in agitation, persistent headache with pain score 9/10, or unresponsiveness to physical stimuli with sluggish pupillary response—requires an immediate call to the provider?
What are the management and treatment options for subarachnoid hemorrhage?
What is the role of beta histidine (histidine) and Stemtil (prochlorperazine) in patients with traumatic subarachnoid hemorrhage (SAH)?
Can I give Toradol (ketorolac) for pain management in a patient with a differential diagnosis of subarachnoid hemorrhage (SAH)?
What is the recommended emergency evaluation and management for a patient with suspected acute subarachnoid hemorrhage?
How to prevent recurrent acute otitis media (AOM) in a 4-month-old infant?
When should extubation (removal of the endotracheal tube) be considered in a ventilator patient?
What are the treatment options for chronic diarrhea?
Can you take tramadol (opioid analgesic) if you are already taking trazodone (antidepressant)?
What is the most appropriate next step in management for a patient with significantly elevated triglycerides (hypertriglyceridemia), normal low-density lipoprotein (LDL) cholesterol, and borderline low high-density lipoprotein (HDL) cholesterol?
Where are saccular aneurysms most likely to occur in the brain vasculature?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.